{
    "Trade/Device Name(s)": [
        "Access Syphilis"
    ],
    "Submitter Information": "Beckman Coulter, Inc",
    "510(k) Number": "K241427",
    "Predicate Device Reference 510(k) Number(s)": [
        "K153730"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LIP"
    ],
    "Summary Letter Date": "May 17, 2024",
    "Summary Letter Received Date": "May 20, 2024",
    "Submission Date": "September 6, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema Pallidum Treponemal Test Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "Total antibodies to Treponema pallidum"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum separator tube",
        "Lithium heparin tube",
        "Lithium heparin separator tube",
        "Dipotassium (K2) EDTA tube",
        "Tripotassium (K3) EDTA tube",
        "Sodium citrate tube",
        "Acid citrate dextrose (ACD) tube",
        "Citrate phosphate dextrose (CPD) tube",
        "Citrate phosphate dextrose with adenine (CPDA) tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Access 2 Immunoassay System",
        "DxI 9000 Access Immunoassay Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Paramagnetic particle chemiluminescent immunoassay",
        "Enzyme immunoassay (EIA)",
        "Automated chemiluminescence"
    ],
    "Methodologies": [
        "Sandwich immunoassay",
        "Chemiluminescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter Access Syphilis paramagnetic particle chemiluminescent immunoassay for detection of total antibodies to Treponema pallidum using Access Immunoassay Systems.",
    "Indications for Use Summary": "Qualitative detection of total antibodies to Treponema pallidum in human serum and plasma as an aid in diagnosis of syphilis infection; not for blood or tissue donor screening.",
    "fda_folder": "Microbiology"
}